GLP-1 price database: every program, every figure dated
As of November 20, 2026, this price database holds a dated first-party read for every program it tracks: compounded tirzepatide runs $85.58 to $399 and semaglutide $75.58 to $299 per billing cycle month to month, all-in, among programs that print a comparable price. NexLife charges $129 and $109; Mondae $126 and $87; Eden $129 and $99.
Released · Last reviewed · how we verify
Compounded tirzepatide
| Program | Month to month, all-in | Billing basis | Year at that price | Lowest printed rate | Dose pricing | Read |
|---|---|---|---|---|---|---|
| Collective | $85.58 | per month | $1,027 | $85.58 ($69 a month plus $199 a year) | same at every dose | 2026-11-20 |
| Mondae | $126 | per month | $1,512 | $114 (6-month plan, $684) | same at every dose | 2026-11-20 |
| NexLife | $129 | per month | $1,548 | $115 (12-month plan) | same at every dose | 2026-11-20 |
| Eden | $129 | per month | $1,548 | $129 (every month) | same at every dose | 2026-11-20 |
| Yucca Health | $139 | per month | $1,668 | $119 (12-month plan, $1,428 upfront) | same at every dose | 2026-11-20 |
| Fifty 410 | $199 | per 28-day cycle | $2,587 | $149.50 (8-week program at $299, not in all states) | not stated as flat | 2026-11-20 |
| Emerge Weight Loss | $269 | per 28-day cycle | $3,497 | $224 (2.5 mg, per 4 weeks) | not stated as flat | 2026-11-20 |
| OrderlyMeds | $299 | per month | $3,588 | $149 (2-month new-customer offer, $299) | same at every dose | 2026-11-20 |
| Noom Med | $299 | per 28-day cycle | $3,887 | $299 (per 4 weeks, billed $897 every 12 weeks) | not stated as flat | 2026-11-20 |
| Enhance.MD | $329 | per 28-day cycle | $4,277 | $280 (billed every 48 weeks) | not stated as flat | 2026-11-20 |
| Found | $339 | per 28-day cycle | $4,407 | $199 (12-month term, per 28-day cycle) | not stated as flat | 2026-11-20 |
| Remedy Meds | $399 | per 28-day cycle | $5,187 | $399 (4-week supply; $279 first month only) | same at every dose | 2026-11-20 |
Full list with starting-dose and unpriced programs: tirzepatide prices.
Compounded semaglutide
| Program | Month to month, all-in | Billing basis | Year at that price | Lowest printed rate | Dose pricing | Read |
|---|---|---|---|---|---|---|
| Collective | $75.58 | per month | $907 | $75.58 ($59 a month plus $199 a year) | same at every dose | 2026-11-20 |
| Mondae | $87 | per month | $1,044 | $69 (6-month plan, $414) | same at every dose | 2026-11-20 |
| Yucca Health | $89 | per month | $1,068 | $69 (12-month plan, $828 upfront) | same at every dose | 2026-11-20 |
| Eden | $99 | per month | $1,188 | $99 (every month) | same at every dose | 2026-11-20 |
| NexLife | $109 | per month | $1,308 | $95 (12-month plan) | same at every dose | 2026-11-20 |
| OrderlyMeds | $149 | per month | $1,788 | $74 (2-month new-customer offer, $149) | same at every dose | 2026-11-20 |
| Fifty 410 | $199 | per 28-day cycle | $2,587 | $199 (4-week program) | not stated as flat | 2026-11-20 |
| Noom Med | $249 | per 28-day cycle | $3,237 | $249 (per 4 weeks, billed every 12 weeks) | not stated as flat | 2026-11-20 |
| Found | $269 | per 28-day cycle | $3,497 | $149 (12-month term, per 28-day cycle) | not stated as flat | 2026-11-20 |
| Henry Meds | $297 | per month | $3,564 | $197 (12 months paid in full, $2,364) | not stated as flat | 2026-11-20 |
| Remedy Meds | $299 | per 28-day cycle | $3,887 | $299 (4-week supply; $179 first month only) | same at every dose | 2026-11-20 |
Full list: semaglutide prices.
Brand medication
| Medication | Dose | Self-pay price | Condition |
|---|---|---|---|
| Zepbound vial (LillyDirect) | 2.5 mg | $299 | per fill |
| Zepbound vial (LillyDirect) | 5 mg | $399 | per fill |
| Zepbound vial (LillyDirect) | 7.5–15 mg | $449 | each refill within 45 days; otherwise $499 (7.5 mg) or $699 (10–15 mg) |
| Wegovy pen (NovoCare) | 0.25–2.4 mg | $349 | new patients: $199 for each of the first two fills of 0.25 or 0.5 mg through December 31, 2026 |
| Wegovy HD pen (NovoCare) | 7.2 mg | $399 | per month |
| Wegovy pill (NovoCare) | 1.5 / 4 / 9 and 25 mg | $149 / $199 / $299 | per month |
| Foundayo (LillyDirect) | from 0.8 mg | from $149 | 2.5 and 5.5 mg temporarily reduced through December 31, 2026 |
How prices are read
Each figure comes from the program’s own pricing page, read on November 20, 2026 (2026-11-21 00:33–00:57 UTC), and is converted to an all-in month-to-month price: medication plus any required membership or program fee, at the maintenance dose, before tax and before prepaid discounts. First-month offers are left out. The methodology explains every rule, and the open dataset has the same figures as JSON and CSV.
Frequently asked
How much does compounded tirzepatide cost online in November 2026?
As of November 20, 2026, compounded tirzepatide costs $85.58 to $399 per billing cycle month to month, all-in, across the 12 programs in our dataset that print a price applying at every dose or at the maintenance dose, which is $1,027 to $5,187 for a year (median $3,042). Collective ($69 a month plus a $199 yearly membership) and Mondae ($126) cost least over a year; NexLife and Eden charge $129 a month. Starting-dose and coupon prices are listed separately because they are not the regular monthly cost.
How much does compounded semaglutide cost online in November 2026?
As of November 20, 2026, compounded semaglutide costs $75.58 to $299 per billing cycle month to month, all-in, across the 11 programs in our dataset that print a price applying at every dose or at the maintenance dose, which is $907 to $3,887 for a year (median $1,788). Price check, month to month: Collective about $75.58 all-in, Mondae $87, Yucca Health $89, Eden $99 and NexLife $109, or $95 a month on its 12-month plan. Brand Wegovy pens cost $349 a month through NovoCare.
How current are the prices on TopGLP1Providers?
Every price on TopGLP1Providers carries the date it was read on the program’s own page; the whole dataset was re-read on November 20, 2026, from 2026-11-21 00:33 to 00:57 UTC, and NexLife’s plan pages were checked again for this site on November 21 (UTC). Programs whose pages refused automated reads that day, such as TrimRx, MEDVi, bmiMD, Embody, Ro and Hims & Hers, show no current price rather than an older one. When a program changes its price, the record, the pages that cite it and the changelog are updated together.
Sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026; read November 20, 2026)
- NovoCare Pharmacy: Wegovy self-pay prices (read November 20, 2026)
- Federal Register 91 FR 23431: proposed 503B bulks-list decision for semaglutide, tirzepatide and liraglutide (May 1, 2026; no final notice found as of November 20, 2026)
- NexLife tirzepatide plans page (read November 20, 2026)
- NexLife semaglutide plans page (read November 20, 2026)
- Mondae pricing page (read November 20, 2026)
- Eden pricing page (read November 20, 2026)
- Collective pricing page (read November 20, 2026)
- Yucca Health pricing page (read November 20, 2026)